Literature DB >> 1752283

Current concepts in cholesterol gallstone pathogenesis.

N Busch1, S Matern.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1752283     DOI： 10.1111/j.1365-2362.1991.tb01394.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN： 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  8 in total

1.  ABO blood group and gall stone disease.

Authors:  T Juvonen; O Niemelä
Journal:  BMJ       Date:  1992-07-04

2.  Changes of lipid metabolism in plasma, liver and bile during cholesterol gallstone formation in rabbit model.

Authors:  Ji-Chun Zhao; Lu-Jia Xiao; Hong Zhu; Ye Shu; Nan-Sheng Cheng
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

3.  Cholesterol crystal binding of biliary immunoglobulin A: visualization by fluorescence light microscopy.

Authors:  F Lammert; S Südfeld; N Busch; S Matern
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

4.  A new subgroup of lectin-bound biliary proteins binds to cholesterol crystals, modifies crystal morphology, and inhibits cholesterol crystallization.

Authors:  N Busch; F Lammert; H U Marschall; S Matern
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

5.  The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects.

Authors:  M Niemi; K Kervinen; A Rantala; H Kauma; M Päivänsalo; M J Savolainen; M Lilja; Y A Kesäniemi
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 6.  Gallbladder motility, gallstones, and the surgeon.

Authors:  R Patankar; M M Ozmen; I S Bailey; C D Johnson
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

7.  Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone Formation.

Authors:  Jing Lin; Ming Lu; Wei-Qing Shao; Zong-You Chen; Wen-Wei Zhu; Lu Lu; Hu-Liang Jia; Duan Cai; Lun-Xiu Qin; Jin-Hong Chen
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

8.  Ursodeoxycholic acid lowers bile lithogenicity by regulating SCP2 expression in rabbit cholesterol gallstone models.

Authors:  Yunfeng Cui; Zhonglian Li; Erpeng Zhao; Ju Zhang; Naiqiang Cui
Journal:  EXCLI J       Date:  2012-08-31       Impact factor: 4.068
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.